FROME ROBERT L
Known title: DirectorCIK: 0000946426
Associated companies
Transaction History
| HCSG | ▲ Buy | Grant | 249 | $3K | 3/31/2025 | View on chart |
| HCSG | ▲ Buy | Grant | 216 | $3K | 12/31/2024 | View on chart |
| HCSG | ▲ Buy | Grant | 224 | $3K | 9/30/2024 | View on chart |
| HCSG | ▲ Buy | Grant | 237 | $3K | 6/30/2024 | View on chart |
| HCSG | ▲ Buy | Grant | 3,728 | $40K | 5/28/2024 | View on chart |
| HCSG | ▲ Buy | Grant | 201 | $3K | 3/31/2024 | View on chart |
| HCSG | ▲ Buy | Grant | 242 | $3K | 12/31/2023 | View on chart |
| HCSG | ▲ Buy | Grant | 240 | $3K | 9/30/2023 | View on chart |
| HCSG | ▲ Buy | Grant | 168 | $3K | 6/30/2023 | View on chart |
| HCSG | ▲ Buy | Grant | 2,835 | $40K | 5/30/2023 | View on chart |
| HCSG | ▲ Buy | Grant | 181 | $3K | 3/31/2023 | View on chart |
| HCSG | ▲ Buy | Grant | 2,330 | $40K | 5/31/2022 | View on chart |
| HCSG | ▲ Buy | Option Exercise | 5,001 | $88K | 1/5/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HCSG Prepares for Q3 Earnings Release
Healthcare Services Group is approaching its third-quarter earnings report, a key event for investors tracking the company's performance. The stock currently trades near its 52-week high, reflecting recent positive momentum. With an average analyst target of $26.67, the market is watching to see if the upcoming results will sustain this upward trend or trigger a pullback.
HCSG Prepares for Q3 Earnings Release. Healthcare Services Group is approaching its third-quarter earnings report, a key event for investors tracking the company's performance. The stock currently trades near its 52-week high, reflecting recent positive momentum. With an average analyst target of $26.67, the market is watching to see if the upcoming results will sustain this upward trend or trigger a pullback.